We’re thrilled to share that our Cohort 8.0 founder Garland Surgical has been awarded a grant from the West Midlands Health Tech Innovation Accelerator (WMHTIA).

This significant funding represents a major milestone in their journey toward the commercialisation of MaltaHip, the innovative ultra-low wear hip replacement designed specifically for younger, active patients.

With the support of the WMHTIA, which is funded by the Department for Science, Innovation and Technology in partnership with Innovate UK and the West Midlands Combined Authority, Garland will be able to accelerate their product rapidly. This grant will enable them to advance the development of MaltaHip, bringing them closer to offering a one-surgery solution that can improve the quality of life for countless individuals.

Share: Share on Twitter Share on LinkedIn

23 May 2025 | Cohort Successes

Split Second Research's Dr Eamon Fulcher (Cohort 8.0)'s article on the concept of the 'Truth Gap'...

Read Article SHARE Share on Twitter Share on LinkedIn

21 May 2025 | Cohort Successes

Karen Nolan has discussed her time on the BetaDen Incubate programme in Innovation Worcestershire...

Read Article SHARE Share on Twitter Share on LinkedIn

19 May 2025 | Cohort Successes

Dan Cook's WebHQ have produced a case study showcasing their collaboration with John Heseltine's...

Read Article SHARE Share on Twitter Share on LinkedIn